Resumen de acción DVA
DaVita Inc. presta servicios de diálisis renal a pacientes con insuficiencia renal crónica en Estados Unidos.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de DaVita Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$142.24 |
| 52 Week High | US$141.54 |
| 52 Week Low | US$71.51 |
| Beta | 1.05 |
| 1 Month Change | 5.33% |
| 3 Month Change | 27.90% |
| 1 Year Change | 63.10% |
| 3 Year Change | 14.43% |
| 5 Year Change | 171.55% |
| Change since IPO | 3,390.54% |
Noticias y actualizaciones recientes
Recent updates
DaVita Stock Is A Hold As It Expands In Latin America
Mar 18Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost
Mar 13
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Mar 04DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 16Is DaVita (NYSE:DVA) Using Too Much Debt?
Feb 08DaVita: Assessing After The Rally
Dec 29DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity
Dec 24DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet
Nov 08DaVita: Simple And Compelling After Sell-Off
Oct 26Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)
Oct 25DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
Oct 05Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?
Aug 14DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt
Jul 31DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold
Jul 21Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down
Jul 18DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jul 03What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?
May 01These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively
Apr 17Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)
Apr 03Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?
Mar 08DaVita HealthCare Partners Q4 2022 Earnings Preview
Feb 21Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine
Feb 08Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Jan 24Is DaVita (NYSE:DVA) A Risky Investment?
Jan 09DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution
Dec 12DaVita Q3 2022 Earnings Preview
Oct 27Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Oct 18DaVita: Solid Valuation And Cash Flow, Price Recovering After SCOTUS Ruling
Sep 28DaVita could benefit from legislation that would return dialysis protection to Medicare
Aug 16We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its Debt
Aug 14DaVita stock dips as peer Fresenius outlook weighed down by labor cost, inflation
Jul 28DaVita: Valuation Turning Attractive
Jul 16Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?
Jul 13Here's Why I Think DaVita (NYSE:DVA) Is An Interesting Stock
May 15DaVita Offers Stability During Market Volatility
May 12Here's Why DaVita (NYSE:DVA) Has A Meaningful Debt Burden
Apr 29Is It Time To Consider Buying DaVita Inc. (NYSE:DVA)?
Apr 14DaVita's Wide Moat Is Undervalued
Feb 11Do DaVita's (NYSE:DVA) Earnings Warrant Your Attention?
Feb 11DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet
Jan 29Rentabilidad de los accionistas
| DVA | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 7.1% | -2.3% | -0.7% |
| 1Y | 63.1% | 0.6% | 22.8% |
Rentabilidad vs. Industria: DVA superó al sector US Healthcare , que obtuvo un rendimiento del 1% el año pasado.
Rentabilidad vs. Mercado: DVA superó al mercado US, que obtuvo un rendimiento del 24.9% el año pasado.
Volatilidad de los precios
| DVA volatility | |
|---|---|
| DVA Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de DVA ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de DVA (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1994 | 70,000 | Javier Rodriguez | www.davita.com |
DaVita Inc. presta servicios de diálisis renal a pacientes con insuficiencia renal crónica en Estados Unidos. La empresa gestiona centros de diálisis renal y presta servicios de laboratorio relacionados en centros de diálisis ambulatorios. También ofrece servicios de hemodiálisis ambulatoria, hospitalaria y domiciliaria; gestiona laboratorios clínicos que proporcionan pruebas de laboratorio rutinarias para diálisis y otras pruebas de laboratorio prescritas por el médico para pacientes con insuficiencia renal terminal; y servicios de gestión y administración a centros de diálisis ambulatorios.
Resumen de fundamentos de DaVita Inc.
| Estadísticas fundamentales de DVA | |
|---|---|
| Capitalización bursátil | US$12.26b |
| Beneficios(TTM) | US$691.54m |
| Ingresos (TTM) | US$12.14b |
18.0x
Ratio precio-beneficio (PE)1.0x
Ratio precio-ventas (PS)¿Está DVA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DVA | |
|---|---|
| Ingresos | US$12.14b |
| Coste de los ingresos | US$8.32b |
| Beneficio bruto | US$3.82b |
| Otros gastos | US$3.13b |
| Beneficios | US$691.54m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 7.88 |
| Margen bruto | 31.47% |
| Margen de beneficio neto | 5.70% |
| Ratio deuda/patrimonio | 296.6% |
¿Cómo se ha desempeñado DVA a largo plazo?
Ver rendimiento histórico y comparativa